Montpellier, France

Hamid Moha Ou Maati

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Medincell. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hamid Moha Ou Maati. Retrieved from https://idiyas.com/inventor/hamid-moha-ou-maati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hamid Moha Ou Maati: Innovator in Antidepressant Research

Introduction

Hamid Moha Ou Maati is a notable inventor based in Montpellier, France. He has made significant contributions to the field of antidepressant research, particularly through his innovative patent work. His dedication to improving mental health treatments has positioned him as a key figure in pharmaceutical advancements.

Latest Patents

Hamid Moha Ou Maati holds a patent titled "Retro-inverso analogs of spadin display increased antidepressant effects." This patent describes compositions, pharmaceutical compositions, and biodegradable pharmaceutical compositions that contain at least one analog of spadin or at least one analog of propeptides of spadin, or mixtures thereof. The patent also discloses methods for treating depression using these analogs, as well as methods for blocking TREK-1 channel activity.

Career Highlights

Throughout his career, Hamid has worked with prominent organizations such as Medincell and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to explore and develop innovative solutions for mental health challenges.

Collaborations

Hamid has collaborated with esteemed colleagues, including Georges Gaudriault and Catherine Louise Heurteaux. These partnerships have further enriched his research and contributed to the advancement of antidepressant therapies.

Conclusion

Hamid Moha Ou Maati's contributions to antidepressant research through his innovative patents and collaborations highlight his commitment to improving mental health treatments. His work continues to inspire advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…